Human Organoids Market Size, Share and Opportunities 2023

The global human organoids market size was valued at USD 2,164.6 million in 2022 and is poised to grow at a significant CAGR of 16.2% during the forecast period 2023-29. Organoids have been progressively used in various applications over the last decade, including disease modelling, pathogenesis, drug screening, and regenerative medicine. This trend is expected to continue during the forecast period. Organoid technologies have advanced significantly in recent years, paving the path for constructing in vitro physiologic systems that simulate the origin tissues with high precision compared to conventional procedures. During the assessment period, the rising emphasis on research and development activities will likely play a significant role in developing the worldwide organoids market.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/human-organoids-market

The global human organoids market is segmented by product type, application, usability, and end user and geography

By Product Type
o Liver
o Kidney
o Pancreas
o Colorectal
o Heart
o Others

By Application
o Developmental biology
o Drug toxicity & efficacy testing
o Disease pathology
o Personalized medicine
o Regenerative medicine
o Other application

By Usability
o Ready to use products
o Customizable products

By End Users
o Pharmaceutical & Biotechnology companies
o CROs
o Academic & Research Institutes
o Others

By Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

The Developmental biology Segment is Dominating the Human Organoids Market:
The Developmental biology segment is expected to account for a larger revenue share, and the market is expected to grow at a double-digit growth rate over the forecast years, owing to the creation of gametes, fertilization, embryo development, the emergence of the adult organism, and senescence are all aspects of developmental biology. Organoids created in culture from stem cells or tissues can be transformed into structures that approximate the in vivo anatomy and physiology of entire organs. Human organoid cultures provide the ability to investigate human development and disease processes at the same level of examination as animal model organism research. Technological breakthroughs in the field of 3D bioprinting have demonstrated enormous potential for organ development because the culture time is much shorter than traditional methods of tissue culture. Patient-derived human organoid studies can speed medical research by opening up new avenues for tissue engineering and regenerative medicine, as well as generating knowledge and tools for preclinical investigations such as drug development and testing.

North America Leads Human Organoids Market
North America is expected to hold a significant market share in the global human organoids market. The market will contribute the most in terms of revenue due to the region's high concentration of pharmaceutical and biotech firms and the strong penetration of human organoid technology. On the other hand, the Asia Pacific market will have the quickest growth over the coming years, mostly because of the rise in liver illnesses, diabetes, and obesity as well as the expanding number of research activities hosted by CROs with Asian headquarters.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players

Global human organoids market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In October 2018, STEMCELL Technologies Inc has announced two cell lines for organoid research in for brain and intestinal cultures.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=419693

Key player's profiles in the Human Organoids Market report are BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic, International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK).

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email:
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.